Publications

Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

 29
Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy

Tags:

Previous Article

Immunotherapy for difficult-to-treat brain tumors with gut microbiota

Next Article

Role of plasmin in metastatic tumors

Related Posts

Oral microbiome and nitric oxide biomarkers in older people with mild cognitive impairment and APOE4 genotype

Oral microbiome and nitric oxide biomarkers in older pe...

 51

Synaptoneurolipidomics: lipidomics in the study of synaptic function

Synaptoneurolipidomics: lipidomics in the study of syna...

 87

Synaptic connectome of the Drosophila circadian clock

Synaptic connectome of the Drosophila circadian clock

 65